Prognostication in 3-vessel coronary artery disease based on left ventricular ejection fraction during exercise :

P G Supino1, J S Borer, E M Herrold

  • 1Division of Cardiovascular Pathophysiology, The Joan and Sanford I. Weill Medical College of Cornell University, The New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY 10021, USA.

Circulation
|September 1, 1999
PubMed

Insights

Left ventricular ejection fraction (LVEF) response to exercise predicts outcomes in 3-vessel coronary artery disease (CAD). Severe ischemia (DeltaLVEF ≤ -8%) identifies patients who benefit from early coronary artery bypass grafting (CABG).

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Nuclear Cardiology

Background:

  • Left ventricular ejection fraction (LVEF) offers prognostic value in coronary artery disease (CAD).
  • The benefit of coronary artery bypass grafting (CABG) may depend on exercise-induced ischemia severity in patients with CAD.

Purpose of the Study:

  • To assess the prognostic significance of preoperative ischemia severity for CABG outcomes in patients with extensive CAD.
  • To determine if exercise-induced ischemia predicts the benefits of CABG.

Main Methods:

  • 167 stable patients with 3-vessel CAD underwent radionuclide cineangiography (rest and exercise).
  • Outcomes were correlated with baseline clinical data, coronary arteriography, and radionuclide testing.
  • Multivariate Cox model analysis was used to identify predictors of cardiac events and CABG benefit.

Main Results:

  • Change in LVEF from rest to exercise (DeltaLVEF) was the strongest independent predictor of major cardiac events (P=0.003) and predicted CABG benefit (P=0.04).
  • Patients with DeltaLVEF ≤ -8% showed significant survival and event reduction with early CABG (<1 month).
  • Benefits of CABG were not observed in patients with DeltaLVEF > -8% or those with delayed surgery.

Conclusions:

  • Exercise-induced ischemia severity, assessed by LVEF response, effectively prognosticates outcomes in 3-vessel CAD.
  • This assessment defines the likelihood of life-prolonging and event-reducing benefits from CABG.
Abstract